195 related articles for article (PubMed ID: 35616298)
1. Design, synthesis, and biological evaluation of triazole-pyrimidine-methylbenzonitrile derivatives as dual A
Li Z; Kou L; Fu X; Xie Z; Xu M; Guo L; Lin T; Gong S; Zhang S; Liu M
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):1514-1526. PubMed ID: 35616298
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of novel scaffold benzo[4,5]imidazo [1,2-a]pyrazin-1-amine: Towards adenosine A
Reddy GL; Sarma R; Liu S; Huang W; Lei J; Fu J; Hu W
Eur J Med Chem; 2021 Jan; 210():113040. PubMed ID: 33316692
[TBL] [Abstract][Full Text] [Related]
3. Novel 1,2,4-triazole derivatives: Design, synthesis, anticancer evaluation, molecular docking, and pharmacokinetic profiling studies.
Turky A; Sherbiny FF; Bayoumi AH; Ahmed HEA; Abulkhair HS
Arch Pharm (Weinheim); 2020 Dec; 353(12):e2000170. PubMed ID: 32893368
[TBL] [Abstract][Full Text] [Related]
4. Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes.
Kim YC; de Zwart M; Chang L; Moro S; von Frijtag Drabbe Künzel JK; Melman N; IJzerman AP; Jacobson KA
J Med Chem; 1998 Jul; 41(15):2835-45. PubMed ID: 9667972
[TBL] [Abstract][Full Text] [Related]
5. The 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A
Falsini M; Squarcialupi L; Catarzi D; Varano F; Betti M; Dal Ben D; Marucci G; Buccioni M; Volpini R; De Vita T; Cavalli A; Colotta V
J Med Chem; 2017 Jul; 60(13):5772-5790. PubMed ID: 28590753
[TBL] [Abstract][Full Text] [Related]
6. Selective adenosine A2A receptor antagonists.
Ongini E; Monopoli A; Cacciari B; Baraldi PG
Farmaco; 2001; 56(1-2):87-90. PubMed ID: 11347973
[TBL] [Abstract][Full Text] [Related]
7. The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A
Squarcialupi L; Betti M; Catarzi D; Varano F; Falsini M; Ravani A; Pasquini S; Vincenzi F; Salmaso V; Sturlese M; Varani K; Moro S; Colotta V
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):248-263. PubMed ID: 28114825
[TBL] [Abstract][Full Text] [Related]
8. Exploring Biginelli-based scaffolds as A
Prieto-Díaz R; Fojo-Carballo H; Majellaro M; Tandarić T; Azuaje J; Brea J; Loza MI; Barbazán J; Salort G; Chotalia M; Rodríguez-Pampín I; Mallo-Abreu A; Rita Paleo M; García-Mera X; Ciruela F; Gutiérrez-de-Terán H; Sotelo E
Biomed Pharmacother; 2024 Apr; 173():116345. PubMed ID: 38442670
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A2A receptor antagonists.
Yang M; Soohoo D; Soelaiman S; Kalla R; Zablocki J; Chu N; Leung K; Yao L; Diamond I; Belardinelli L; Shryock JC
Naunyn Schmiedebergs Arch Pharmacol; 2007 Apr; 375(2):133-44. PubMed ID: 17310264
[TBL] [Abstract][Full Text] [Related]
10. Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors.
Beavis PA; Divisekera U; Paget C; Chow MT; John LB; Devaud C; Dwyer K; Stagg J; Smyth MJ; Darcy PK
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14711-6. PubMed ID: 23964122
[TBL] [Abstract][Full Text] [Related]
11. 1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists.
Hayallah AM; Sandoval-Ramírez J; Reith U; Schobert U; Preiss B; Schumacher B; Daly JW; Müller CE
J Med Chem; 2002 Mar; 45(7):1500-10. PubMed ID: 11906291
[TBL] [Abstract][Full Text] [Related]
12. Release of adenosine-induced immunosuppression: Comprehensive characterization of dual A
Dziedzic K; Węgrzyn P; Gałęzowski M; Bońkowska M; Grycuk K; Satała G; Wiatrowska K; Wiklik K; Brzózka K; Nowak M
Int Immunopharmacol; 2021 Jul; 96():107645. PubMed ID: 33894488
[TBL] [Abstract][Full Text] [Related]
13. 7-Substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: a study on the importance of modifications at the side chain on the activity and solubility.
Baraldi PG; Cacciari B; Romagnoli R; Spalluto G; Monopoli A; Ongini E; Varani K; Borea PA
J Med Chem; 2002 Jan; 45(1):115-26. PubMed ID: 11754583
[TBL] [Abstract][Full Text] [Related]
14. 2-Aminopyrimidines as dual adenosine A1/A2A antagonists.
Robinson SJ; Petzer JP; Terre'Blanche G; Petzer A; van der Walt MM; Bergh JJ; Lourens AC
Eur J Med Chem; 2015 Nov; 104():177-88. PubMed ID: 26462195
[TBL] [Abstract][Full Text] [Related]
15. Differences in the order of potency for agonists but not antagonists at human and rat adenosine A2A receptors.
Kull B; Arslan G; Nilsson C; Owman C; Lorenzen A; Schwabe U; Fredholm BB
Biochem Pharmacol; 1999 Jan; 57(1):65-75. PubMed ID: 9920286
[TBL] [Abstract][Full Text] [Related]
16. Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors.
Ongini E; Dionisotti S; Gessi S; Irenius E; Fredholm BB
Naunyn Schmiedebergs Arch Pharmacol; 1999 Jan; 359(1):7-10. PubMed ID: 9933143
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel thiazolo[5,4-d]pyrimidine derivatives as human A
Varano F; Catarzi D; Falsini M; Vincenzi F; Pasquini S; Varani K; Colotta V
Bioorg Med Chem; 2018 Jul; 26(12):3688-3695. PubMed ID: 29880250
[TBL] [Abstract][Full Text] [Related]
18. Replacement of amide with bioisosteres led to a new series of potent adenosine A2A receptor antagonists.
Yang Z; Li X; Ma H; Zheng J; Zhen X; Zhang X
Bioorg Med Chem Lett; 2014 Jan; 24(1):152-5. PubMed ID: 24332624
[TBL] [Abstract][Full Text] [Related]
19. Discovery of Potent and Highly Selective A2B Adenosine Receptor Antagonist Chemotypes.
El Maatougui A; Azuaje J; González-Gómez M; Miguez G; Crespo A; Carbajales C; Escalante L; García-Mera X; Gutiérrez-de-Terán H; Sotelo E
J Med Chem; 2016 Mar; 59(5):1967-83. PubMed ID: 26824742
[TBL] [Abstract][Full Text] [Related]
20. Identification of a New Series of Potent Adenosine A
Yang Z; Li L; Zheng J; Ma H; Tian S; Li J; Zhang H; Zhen X; Zhang X
ACS Chem Neurosci; 2016 Nov; 7(11):1575-1584. PubMed ID: 27569066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
